A-Mansia (@a_mansia) profile picture

A-Mansia is the latest co-spin-off from the University of Louvain (UCL) and Wageningen University. It aims to develop Akkermansia-based products.

Ottignies-Louvain-la-Neuve
Joined October 2016
Photo by A-Mansia (@a_mansia)
[Heath for Life Capital I ™ annual conference] @a_mansia is using next-generation beneficial microbes restoring the gut barrier function. #Aktigut® : the first dietary supplements containing pasteurized A.muciniphila to tackle the root cause of #obesity & #prediabetes
2
3
Don’t miss our booth (M93) at Vitafoods 2019! #VFE19 #Vitafoods2019
1
8
#Microbiome : En vidéo, une #bactérie attrape de l'ADN ow.ly/fs2830kvKZC @futurasciences
1
1
Session 9 of @BENEFIQ_Expo on October 3 features Dr. Maria L. Marco, expert in lactic acid bacteria in food systems and as part of the gut microbiome. Presented by @biokplus. @INAF_Qc @universitelaval
This new open access review presents the MiBioGen consortium as the latest project related to microbiota-genome-wide association studies. With 18 population cohorts & 19,000 subjects it will provide a fuller picture of the human gut microbiome ow.ly/qI2h30kvc7j
5
8
Our Founder and CEO Najla Guthrie participated as a judge for the NCN Venture Den contest at #Vitafoods2018! Congratulations to the winner A-Mansia! We love seeing new talent in the industry. #VFE2018 @VitafoodsEurope
5
2
12
A-Mansia biotech, a spin-off from Wageningen University in the Netherlands and the University of Louvain in Belgium, has secured €13M in Series A financing. The company will put the funding towards developing its technology, which uses Akkermansia muciniphila, a gut bacterium.
2
8
17